We simplify market access with actionable, research-driven insights

By leveraging proprietary research and data, expert consultations, and deep stakeholder insights, we help our make data-driven decisions that drive both strategic success and patient access. With MARIN, our clients know the data and know the strategy to navigate market challenges effectively.

Areas of Research

An icon representing an integrated delivery network.

Integrated Delivery Networks

IDNs have a significant and growing impact on drug utilization and access, making them a crucial focus for biopharmaceutical companies.

An icon representing community ties.

Community Oncology

With a focus on delivering personalized care close to home, these practices are essential to ensuring that cancer therapies reach broader patient populations.

A shield-like icon.

Payers

Payers’ oncology drug management strategies are shifting. Understanding these changes and the trends behind them is essential for pharmaceutical companies.

2025 Landscape Updates
Featured Product

2025 Landscape Updates Report

As the oncology landscape rapidly evolves, keeping pace with market changes is crucial for optimizing your market access strategies. The 2024 Landscape Updates Reports provide essential intelligence to help pharmaceutical companies understand and respond to the shifting dynamics of cancer care.

Meet the team

MARIN helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.”

Natasha Brown
Collage with a close up of a person's eyes staring intently, overlaid with graphics representing various complex data structures.

Oncology market access—unlocked

Access all of MARIN’s exclusive reports through our Research Portal—your gateway to the latest oncology market intelligence. By logging in, you unlock a wealth of valuable resources designed to empower your strategic decisions in the oncology landscape.

Get in touch
 
Participate in Our Research

Pharmacists, physicians, and payer executives with expertise in oncology participate in our research focus groups, one-on-one interviews, and quantitative web-based surveys.

Learn More